Intrinsic Value of S&P & Nasdaq Contact Us

Angion Biomedica Corp. ANGN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+50%

Angion Biomedica Corp. (ANGN) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 1 Buy, 3 Hold.

The consensus price target is $1.50, representing an upside of 50% from the current price $1.00.

ANGN Stock — 12-Month Price Forecast

$1.50
▲ +50.00% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Angion Biomedica Corp., the price target is $1.50.
The average price target represents a +50.00% change from the last price of $1.00.

ANGN Analyst Ratings

Hold
4
Ratings
1 Buy
3 Hold
Based on 4 analysts giving stock ratings to Angion Biomedica Corp. in the past 3 months
Rating breakdown
Buy
1 25%
Hold
3 75%
25%
Buy
1 analysts
75%
Hold
3 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message